#SaveTheDate: 27-28/07
Masterclass online de Andreu Soldevila, cofundador y CEO de #SynaTherapeutics, nuestra joint venture junto con @leanbiopro, en las jornadas #CMC Biopharma de @GLCEurope
Inscripciones: https://t.co/j1I4PmPBWy
#SynaTherapeutics es nuestra joint venture con @leanbiopro para la investigación y desarrollo de medicamentos #biosimilares. Pero... ¿qué son los medicamentos biosimilares? @BioSim_es lo explica en este Decálogo: https://t.co/HpyEhJ0UXn
Is your strategy for #pharma manufacturing effective?
💻 CMC Biopharma Online Masterclass
🗓️ 27 and 28 July
🗣️ Led by Dr Andreu Soldevila, co-founder and CEO of Syna Therapeutics (joint venture of @ReigJofre and @leanbiopro)
🔗 Sign up! https://t.co/cdOYSHsioe
¡Creamos junto con @leanbiopro la joint-venture Syna Therapeutics! Esta alianza centra su actividad en el desarrollo de productos biofarmacéuticos, en el ámbito de los biosimilares y moléculas innovadoras, para un mercado mundial https://t.co/t5GmxIO9hf
In Leanbio Pro we are committed to provide to the society biotechnological solutions in this moment. Feel free to contact us and share your needs about treating #COVID-19, we are experts in manufacturing antigens, vaccines, antibodies, antibody fragments… #Coronavirus#Biologics
During these days it is so important to stay safe, taking care of the team and family. We are pleased to inform that there has been nobody infected by Covid-19 in Leanbio! Take care and always follow all the recommendations from authorities.
#COVID19#LeanbioPro#CDMO#StayHome
We have been selected as semifinalists of Merck 2020 European Advance Biotech Grant Program!
Thank you so much for the opportunity!!!
https://t.co/sxBjdR88gp